280
- Burnier M, Pruijm M, Wuerzner G, Santschi V. Drug adherence in chronic kidney diseases and
dialysis. Nephrol Dial Transplant. 2015;30(1):39–44. - Kidney Disease Outcomes Quality Initiative (K/DOQI). K/DOQI clinical practice guidelines
on hypertension and antihypertensive agents in chronic kidney disease. Am J Kidney Dis.
2004;43(5 suppl):1–290. - Sarafidis PA, Li S, Chen SC, Collins AJ, Brown WW, Klag MJ, Bakris GL. Hypertension
awareness, treatment, and control in chronic kidney disease. Am J Med. 2008;121(4):332–40. - Schmitt KE, Edie CF, Laflam P, Simbartl LA, Thakar CV. Adherence to antihypertensive
agents and blood pressure control in chronic kidney disease. Am J Nephrol. 2010;32(6):541–8. - Muntner P, Judd SE, Krousel-Wood M, McClellan WM, Safford MM. Low medication adher-
ence and hypertension control among adults with CKD: data from the REGARDS (Reasons for
Geographic and Racial Differences in Stroke) Study. Am J Kidney Dis. 2010;56(3):447–57. - Bailie GR, Eisele G, Liu L, Roys E, Kiser M, Finkelstein F, Wolfe R, Port F, Burrows-Hudson
S, Saran R. Patterns of medication use in the RRICKD study: focus on medications with car-
diovascular effects. Nephrol Dial Transplant. 2005;20:1110–5. - Chiu YW, Teitelbaum I, Misra M, de Leon EM, Adzize T, Mehrotra R. Pill burden, adher-
ence, hyperphosphatemia, and quality of life in maintenance dialysis patients. Clin J Am Soc
Nephrol. 2009;4(6):1089–96. - Sabate E. Adherence to long-term therapies: evidence for action. Geneva: World Health
Organization; 2003. - Schmid H, Hartmann B, Schiffl H. Adherence to prescribed oral medication in adult
patients undergoing chronic hemodialysis: a critical review of the literature. Eur J Med Res.
2009;14(5):185–90. - Magacho EJ, Ribeiro LC, Chaoubah A, Bastos MG. Adherence to drug therapy in kidney
disease. Braz J Med Biol Res. 2011;44(3):258–62. - Moreira L, Fernandes P, Monte S, Martins A. Adesão ao tratamento farmacológico em pacien-
tes com doença renal crônica. J Bras Nefrol. 2008;30:113–9. - Lee JY, Greene PG, Douglas M, Grim C, Kirk KA, Kusek JW, Milligan S, Smith DE, Whelton
PK. Appointment attendance, pill counts, and achievement of goal blood pressure in the
African American Study of Kidney Disease and Hypertension Pilot Study. Control Clin Trials.
1996;17(4 Suppl):34S–9S. - Vrijens B, Vincze G, Kristanto P, Urquhart J, Burnier M. Adherence to prescribed antihyper-
tensive drug treatments: longitudinal study of electronically compiled dosing histories. BMJ.
2008;336(7653):1114–7. - Grymonpre RE, Didur CD, Montgomery PR, Sitar DS. Pill count, self-report, and phar-
macy claims data to measure medication adherence in the elderly. Ann Pharmacother.
1998;32(7-8):749–54. - Neri L, Martini A, Andreucci VE, Gallieni M, Rey LA, Brancaccio D, MigliorDialisi Study
Group. Regimen complexity and prescription adherence in dialysis patients. Am J Nephrol.
2011;34(1):71–6. - Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of
death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351(13):1296–305. - U.S. Renal Data System, USRDS. 2013 Annual data report: atlas of chronic kidney disease and
end-stage renal disease in the United States. Bethesda: National Institutes of Health, National
Institute of Diabetes and Digestive and Kidney Diseases; 2013. - Stevens LA, Coresh J, Greene T, Levey AS. Assessing kidney function—measured and esti-
mated glomerular filtration rate. N Engl J Med. 2006;354(23):2473–83. - Hepler CD, Strand LM. Opportunities and responsibilities in pharmaceutical care. Am J Hosp
Pharm. 1990;47(3):533–43. - McFarland MS, Cross LB, Gross B, Gentry C, Tunney J, Patel UP. Drug use evaluation
of sitagliptin dosing by pharmacist versus nonpharmacist clinicians in an internal medi-
cine department of a private physician-owned multispecialty clinic. J Manag Care Pharm.
2009;15(7):563–7.
A. Kirkpantur and B. Afsar